Both in Pharmaceuticals
Nature's Sunshine Products vs Greenwich LifeSciences
Over the past year NATR returned −10.2% and GLSI returned +72.7%; their daily moves had a correlation of 0.08.
NATR −10.2% GLSI +72.7%Growth of $1, one year, split-adjusted
| Metric | NATR | GLSI |
|---|---|---|
| Price | $12.35 | $16.91 |
| Market cap | $217.3M | $248.2M |
| Today | +0.65% | −1.26% |
| 1 month | −3.7% | −9.0% |
| 6 months | −54.6% | −25.8% |
| Year to date | −42.8% | −19.5% |
| 1 year | −12.4% | +69.3% |
| Revenue growth (YoY) | +1.9% | — |
| Gross margin | 73.7% | — |
| Net margin | 3.0% | — |
| P/E (TTM) | 12.0× | — |
| Price / sales | 0.4× | — |
| Net cash | $82.5M | $8.9M |
| Dividend yield | — | — |
| Volatility (60d) | 48.3% | 90.2% |
| Short % of float | 6.4% | 24.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).